StockData

SOPHiA GENETICS vs Veritone

SOPH and VERI side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SOPH and VERI compare

SOPHiA GENETICS grew revenue faster over the last twelve months (18.6% versus 1.1% for Veritone).

SOPHiA GENETICS keeps more of each dollar of sales as profit, with a net margin of −102% compared with −118% at Veritone.

Veritone scores higher on the StockData Score (7 against 4 for SOPHiA GENETICS), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSOPHVERI
Size and price
Market cap–$37.2M
Share price$7.44$0.370
Change, 1 year69.9%−91.3%
Change, 5 years−48.5%−98.6%
Beta (5Y)1.833.00
Employees415446
StockData Score
Total score47 (better)
Valuation score03 (better)
Growth score2 (better)0
Performance score1 (better)0
Health score14 (better)
Dividend score00
Valuation
P/S–0.4×
P/B–1.0×
FCF yield–−147%
Fair value–$1.59
Margin of safety–76.7%
Growth
Revenue growth (TTM)18.6% (better)1.1%
Revenue growth, 5Y average22.2% (better)9.8%
Profitability
Gross margin67.4% (better)66.2%
Operating margin−91.8%−90.2% (better)
Net margin−102% (better)−118%
FCF margin−47.2% (better)−60.1%
Return on equity–−518%
Return on invested capital–−845%
Financial health
Debt / equity–0.00
Interest coverage−15.6×–
Current ratio2.69 (better)0.47
Altman Z-score–−7.29
Piotroski F-score23 (better)
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions–27.5%
Held by insiders11.0%12.2%
Insider net buying, 12 months−$4.9M$126K (better)
Short interest, % of float1.9%14.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.